Skip to content

Clareon CNW0T3 (UDI 00380652409773)Recalls & reported problems

Alcon Laboratories, Inc. · CLAREON BLF TORIC · Class 3 · Implant

All models of Clareon (1142)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00380652409773), received between Mar 17, 2025 and Oct 20, 2025 — classified as 2 injuries, 2 malfunctions.

The most frequently reported specific device problem is “Material Discolored” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 1 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Material Discolored1
  • Material Opacification1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Visual Disturbances2
  • Blurred Vision1
  • Foreign Body Sensation in Eye1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 20, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ADDITIONAL INFORMATION RECEIVED AND REPORTED THAT THE IOL WAS EXCHANGED FOR THE DIFFERENT LENS MODEL BUT FOUR A DIOPTER LESS POWER INDICATING THE CORRECT LENS POWER WAS NOT IMPLANTED INITIALLY. THERE IS NO REPORTED DEFECT OR FAULT WITH THE IOL.

    Patient problems: Blurred Vision; Foreign Body Sensation in Eye; Visual Disturbances

    MAUDE report 23334844 ↗
  • InjuryMay 28, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PHYSICIAN REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANTATION PROCEDURE, THE PATIENT BEGAN EXPERIENCING HALOS AND GLARE, RESULTING IN AN INABILITY TO DRIVE AT NIGHT. THE PATIENT WAS ADVISED TO CONTINUE USING PRESERVATIVE-FREE ARTIFICIAL TEARS (LUBRICATING EYE DROPS) 3¿4 TIMES DAILY. ADDITIONALLY, A TAPERING REGIMEN OF A CORTICOSTEROID WAS INITIATED, WITH INSTRUCTIONS TO INSTILL ONE DROP IN THE RIGHT EYE (OD) ONCE DAILY FOR ONE WEEK. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Visual Disturbances

    MAUDE report 22095827 ↗
  • MalfunctionApr 29, 2025Material Discolored; Material Discolored

    A PHYSICIAN REPORTED THAT AFTER IMPLANTATION OF LENS DURING THE INTRAOCULAR LENS (IOL) IMPLANTATION PROCEDURE, THE IOL LOOKED BLUE IMMEDIATELY. THE SURGERY WAS COMPLETED WITHOUT PRODUCT REPLACEMENT. IT WAS UNKNOWN WHETHER THESE FINDINGS DISAPPEARED OR CONTINUED. THE LENS REMAINED IMPLANTED. THERE HAVE BEEN NO REPORTED HEALTH PROBLEMS OR HARM TO THE PATIENT. ADDITIONAL INFORMATION WAS REQUESTED, BUT NO FURTHER INFORMATION IS AVAILABLE. THERE ARE 224 MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS EVENT. THIS IS 7 OF 224.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21926305 ↗
  • MalfunctionMar 17, 2025Material Opacification; Material Opacification

    A SURGEON REPORTED DURING INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE SURGEON NOTICED A WIPEABLE FILM ON THE IOL WHICH COULD BE REMOVED SOMEWHAT AFTER IMPLANTATION WITH THE BIMANUAL IRRIGATION/ASPIRATION (I/A) HANDPIECES. THERE WAS A PATIENT CONTACT AND IOL HAD REMAINED IN THE PATIENT EYES. THE PROCEDURE WAS COMPLETED ON SAME DAY WITHOUT ANY HARM TO THE PATIENT. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND RECEIVED AS PER SURGEON WIPEABLE FILM ON THE INTRAOCULAR LENS (IOL) WAS A FINE, IRREGULAR, STRUCTURED AND THIN DEPOSIT WHICH CAN BE DRAW A TRACK WITH AN INSTRUMENT (EXAMPLE REPORTED AS A RINSING HANDLE), SO ABRASION WOULD BE POSSIBLE. WIPEABLE FILM ON THE IOL WAS VISIBLE BEFORE CONTACT WITH VISCOELASTIC. IN SURGEON OWN CASE LENS EPITHELIUM MIGRATION ALSO TOOK PLACE QUITE QUICKLY ON THIS LAYER. SURGEON HAD ONLY SEEN ONE CASE AND MOSTLY OTHER PATIENTS ARE REFERRED. SURGEON WOULD NOT SEE THEM AGAIN. THERE ARE THREE MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS COMPLAINT. THIS REPORT IS 1 OF 3.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21621854 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page